BC
TDOC icon

Burleson & Co’s Teladoc Health TDOC Stock Holding History

Burleson & Co’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-100
Closed -$3K – 454
2022
Q3 		$3K Sell
100
-11
-10% -$386 ﹤0.01% 336
2022
Q2 		$4K Sell
111
-111,193
-100% -$4.72M ﹤0.01% 306
2022
Q1 		$8.03M Buy
111,304
+101,292
+1,012% +$7.3M 1.29% 23
2021
Q4 		$919K Buy
+10,012
New +$1.2M 0.13% 82

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Burleson & Co's TDOC Position: Q4 2022 in Review

Burleson & Co sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 100 shares — an estimated $3K sold.

Burleson & Co first reported a position in TDOC in Q4 2021 and held it in 4 quarters. The position peaked at $8.03M in Q1 2022. 445 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Burleson & Co reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Burleson & Co sold 100 Teladoc Health shares in Q4 2022, an estimated $3K.
  • Burleson & Co first reported a position in Teladoc Health in Q4 2021 and held it in 4 quarters.
  • Burleson & Co's Teladoc Health position peaked at $8.03M in Q1 2022.
  • 445 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Burleson & Co's 13F filing for Q4 2022, filed 31 Jan 2023.